The Outcome of COVID-19 Infection in Patients With Gastrointestinal Diseases: An Experience at a Tertiary Center

Tafaj, Irgen; Cuko, Liri; Çili, Qazim; Hysenj, Arlinda; Sadiku, Edite

doi:10.7759/cureus.35629

Cited by 1 publication

(1 citation statement)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nonetheless, the list of possible extrapulmonary symptoms and complications became longer and longer [4][5][6][7][8]. Finally, the spectrum of COVID-19related manifestations turned out to be associated with a broad range of systemic symptoms, e.g., neurological and dermatological syndromes, myocardial dysfunction, hyperglycemia, disorders of the gastrointestinal tract and acute kidney failure [9][10][11][12][13][14]. Concomitantly, a lot of observations also started to suggest an existing relationship between SARS-CoV-2 and chronic liver diseases (CLDs), indicating hepatic manifestations of the infection and the exacerbation of existing liver pathologies in the case of COVID-19 [15][16][17][18][19][20][21].…”

Section: Introductionmentioning

confidence: 99%

COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?

Michalak,

Lach,

Szczygieł

et al. 2024

IJMS

View full text Add to dashboard Cite

The pandemic period due to coronavirus disease 2019 (COVID-19) revolutionized all possible areas of global health. Significant consequences were also related to diverse extrapulmonary manifestations of this pathology. The liver was found to be a relatively common organ, beyond the respiratory tract, affected by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Multiple studies revealed the essential role of chronic liver disease (CLD) in the general outcome of coronavirus infection. Present concerns in this field are related to the direct hepatic consequences caused by COVID-19 and pre-existing liver disorders as risk factors for the severe course of the infection. Which mechanism has a key role in this phenomenon—previously existing hepatic disorder or acute liver failure due to SARS-CoV-2—is still not fully clarified. Alcoholic liver disease (ALD) constitutes another not fully elucidated context of coronavirus infection. Should the toxic effects of ethanol or already developed liver cirrhosis and its consequences be perceived as a causative or triggering factor of hepatic impairment in COVID-19 patients? In the face of these discrepancies, we decided to summarize the role of the liver in the whole picture of coronavirus infection, paying special attention to ALD and focusing on the pathological pathways related to COVID-19, ethanol toxicity and liver cirrhosis.

show abstract

Section: Introductionmentioning

confidence: 99%

COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?

Michalak,

Lach,

Szczygieł

et al. 2024

IJMS

View full text Add to dashboard Cite

show abstract

The Outcome of COVID-19 Infection in Patients With Gastrointestinal Diseases: An Experience at a Tertiary Center

Abstract: Objective: Observing the impact of the coronavirus disease 2019 (COVID-19) pandemic on digestive diseases in hospitalized patients at the

Cited by 1 publication

References 27 publications

COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?

COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?

Contact Info

Product

Resources

About